NCT07523425Recruiting
Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation
COMPARATIVE EFFECTIVENESS of COLLABORATIVE VIRTUAL ENVIRONMENT and NON-IMMERSIVE VIRTUAL REALITY in the REHABILITATION of PATIENTS With PARKINSON'S DISEASE
Source: ClinicalTrials.gov · Last updated 15 Apr 2026
Brief summary (registry, in English)
This randomized controlled trial aims to compare the effectiveness of a Collaborative Virtual Reality Environment (CVE) and Non-Immersive Virtual Reality (NIVR) in the rehabilitation of patients with Parkinson's disease. Participants with mild to moderate disease severity will be randomly assigned to either the CVE group or the NIVR group. The CVE intervention will involve therapist-guided, interactive virtual exercises in a shared environment, promoting real-time engagement and feedback. The NIVR group will perform task-oriented exercises using screen-based virtual reality without immersive and collaborative features. Both interventions will be delivered over an 12-week period. Primary outcomes will assess motor function using standardized clinical scales, while secondary outcomes will evaluate cognitive function, mobility, and quality of life. The study seeks to determine whether collaborative and interactive virtual rehabilitation provides superior clinical outcomes compared to conventional non-immersive virtual approaches in patients with Parkinson's disease.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 5 Apr 2026
- Start date
- 27 May 2025
- Primary completion date
- 27 Sept 2026
- Lead sponsor
- Superior University
- Diseases
- Parkinson disease
- NCT number
- NCT07523425
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 27 May 2025 to the primary completion date, 27 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Comorbidities that hinder participation in the treatment (e.g., advanced dementia).
- Severe musculoskeletal conditions limiting movement
- History of epilepsy or conditions contraindicating virtual reality exposure
Other
- Severe visual, auditory, or motor impairments unrelated to Parkinson's.
- Fear of virtual environment.
- Participation in another interventional study within the last 3 months
Who the study is looking for
- Male and Female
- Age: 45 years-80 Years
- Diagnosed patients of idiopathic Parkinson Disease with minor to moderate severity according to the Hoehn \& Yahr stages I-III.
- On conventional and stable medical treatment at present
- No severe cognitive impairments (MMSE ≥ 24).
- Ability to participate in virtual rehabilitation sessions
- Willingness to participate and provide informed consent
Age in the registry: 45 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Punjab Institute of Neurosciences Lahore Coordinator of this site? Confirm its status | Lahore | Pakistan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.